- Previous Close
0.0000 - Open
0.0000 - Bid --
- Ask --
- Day's Range
0.0000 - 0.0000 - 52 Week Range
0.0000 - 0.1000 - Volume
1,000 - Avg. Volume
2 - Market Cap (intraday)
125 - Beta (5Y Monthly) -1.58
- PE Ratio (TTM)
-- - EPS (TTM)
-0.7200 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Bionik Laboratories Corp., a robotics company, engages in designing, developing, and commercializing physical rehabilitation technologies, prosthetics, and assisted robotic products. It offers InMotion Robots, which include a suite of robotic rehabilitation products; InMotion ARM, an evidence-based intelligent interactive rehabilitation technology that senses patient movements and limitations; InMotion ARM/HAND, which provides support for therapy involving reaching with grasp and release movements, and individual hand movements; and InMotion Connect platform that consists of a hardware device connected to the InMotion Robot, as well as a subscription to InMotion Connect Pulse. Bionik Laboratories Corp. was incorporated in 2010 and is headquartered in Watertown, Massachusetts.
www.bioniklabs.comRecent News: BNKL
View MorePerformance Overview: BNKL
Trailing total returns as of 11/21/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: BNKL
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: BNKL
View MoreValuation Measures
Market Cap
124.00
Enterprise Value
1.99M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.00
Price/Book (mrq)
--
Enterprise Value/Revenue
1.10
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-273.99%
Return on Assets (ttm)
-74.23%
Return on Equity (ttm)
-768.84%
Revenue (ttm)
1.81M
Net Income Avi to Common (ttm)
-4.95M
Diluted EPS (ttm)
-0.7200
Balance Sheet and Cash Flow
Total Cash (mrq)
427.38k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-1.58M